TIDMAGL

RNS Number : 4613G

Angle PLC

04 March 2015

 
 For immediate release    4 March 2015

ANGLE plc

("ANGLE" or "the Company")

OFFER TO SHAREHOLDERS TO RAISE UP TO GBP1.5 MILLION

On 16 February 2015, ANGLE plc (AIM: AGL and OTCQX: ANPCY), the specialist medtech company, announced an issue of equity to raise GBP7.3 million (before expenses) by way of a Placing and Subscription. In conjunction with the Placing and Subscription, the Board also announced details of an Offer to Qualifying Participants to raise up to an additional GBP1.5 million (before expenses) through the issue of up to 2,307,692 New Ordinary Shares at an Issue Price of 65 pence per Ordinary Share.

The Company is pleased to announce that the Offer, which closed at 11.00 a.m. on 2 March 2015, was more than four times oversubscribed. The Offer raised the Offer Maximum of GBP1.5 million and, accordingly, 2,307,692 New Ordinary Shares have been issued. It is expected that Qualifying Participants that applied for the Offer will each receive approximately 21.75% of their applications.

Application has been made for 2,307,692 New Ordinary Shares to be admitted to trading on AIM. It is expected that admission to AIM will become effective on 10 March 2015.

Further details of the Placing, Subscription and Offer were set out in the announcement published by the Company on 16 February 2015.

Unless otherwise defined, capitalised terms shall have the same meaning as defined in the circular posted to Shareholders on 16 February 2015 (the "Circular"), which is available to view on the Company's website at www.angleplc.com.

ANGLE's Founder and Chief Executive, Andrew Newland, commented:

"We are delighted to have received such a strong level of support from our retail shareholders with the Offer more than four times over-subscribed. In total we have raised GBP8.2 million net of expenses in our Placing, Subscription and Offer, which puts ANGLE in a strong position to progress its first clinical application in ovarian cancer."

For further information:

 
 ANGLE plc                                  01483 685830 
 Andrew Newland, Chief Executive 
  Ian Griffiths, Finance Director 
 Cenkos Securities 
  Stephen Keys, Dr Christopher Golden 
  (Nominated adviser) 
  Russell Kerr, Oliver Baxendale (Sales)    020 7397 8900 
 Buchanan 
  Mark Court, Sophie Cowles, Jane Glover    020 7466 5000

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEJJMJTMBTMTJA

Angle (LSE:AGL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Angle Charts.
Angle (LSE:AGL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Angle Charts.